File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0023677253
- PMID: 2459508
- WOS: WOS:A1988P544300005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Are there interactions between S2-serotonergic and α1-adrenergic receptors in isolated canine arteries?
Title | Are there interactions between S2-serotonergic and α1-adrenergic receptors in isolated canine arteries? |
---|---|
Authors | |
Issue Date | 1988 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ |
Citation | Journal Of Cardiovascular Pharmacology, 1988, v. 11 SUPPL. 1, p. S16-S21 How to Cite? |
Abstract | Experiments were performed to examine the interaction(s) between α1-adrenergic and S2-serotonergic receptors of vascular smooth muscle of the dog. Rings of isolated coronary and femoral arteries (without endothelium) were suspended for isometric tension recording in organ chambers filled with modified Krebs-Ringer bicarbonate solution. 5-Hydroxytryptamine (serotonin) augmented the responsiveness to norepinephrine in the coronary artery (log shift at ED50 of the concentration-response curve: 2.9-fold). In the femoral artery, the contractions to either norepinephrine or the partial α1-adrenergic agonist St 587 were unchanged by serotonin. Ketanserin (10- M) augmented the response to the full α1-adrenergic agonist phenylephrine, but not to that of St 587; at 5 x 10-9 M, it depressed the contractions to phenylephrine. Ketanserin did not affect the α1-adrenergic blocking properties of prazosin. By contrast, prazosin, in a concentration selective for α1-adrenergic receptors, potentiated the inhibitory effect of ketanserin on contractions evoked by serotonin. These experiments suggest different interactions between S2-serotonergic and α1-adrenergic receptors in the canine coronary and femoral artery. |
Persistent Identifier | http://hdl.handle.net/10722/170866 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.610 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Luscher, TF | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:11:10Z | - |
dc.date.available | 2012-10-30T06:11:10Z | - |
dc.date.issued | 1988 | en_US |
dc.identifier.citation | Journal Of Cardiovascular Pharmacology, 1988, v. 11 SUPPL. 1, p. S16-S21 | en_US |
dc.identifier.issn | 0160-2446 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170866 | - |
dc.description.abstract | Experiments were performed to examine the interaction(s) between α1-adrenergic and S2-serotonergic receptors of vascular smooth muscle of the dog. Rings of isolated coronary and femoral arteries (without endothelium) were suspended for isometric tension recording in organ chambers filled with modified Krebs-Ringer bicarbonate solution. 5-Hydroxytryptamine (serotonin) augmented the responsiveness to norepinephrine in the coronary artery (log shift at ED50 of the concentration-response curve: 2.9-fold). In the femoral artery, the contractions to either norepinephrine or the partial α1-adrenergic agonist St 587 were unchanged by serotonin. Ketanserin (10- M) augmented the response to the full α1-adrenergic agonist phenylephrine, but not to that of St 587; at 5 x 10-9 M, it depressed the contractions to phenylephrine. Ketanserin did not affect the α1-adrenergic blocking properties of prazosin. By contrast, prazosin, in a concentration selective for α1-adrenergic receptors, potentiated the inhibitory effect of ketanserin on contractions evoked by serotonin. These experiments suggest different interactions between S2-serotonergic and α1-adrenergic receptors in the canine coronary and femoral artery. | en_US |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ | en_US |
dc.relation.ispartof | Journal of Cardiovascular Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Coronary Vessels - Drug Effects - Physiology | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Femoral Artery - Drug Effects - Physiology | en_US |
dc.subject.mesh | Ketanserin - Pharmacology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Muscle Contraction - Drug Effects | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Drug Effects - Physiology | en_US |
dc.subject.mesh | Norepinephrine - Pharmacology | en_US |
dc.subject.mesh | Phenylephrine - Pharmacology | en_US |
dc.subject.mesh | Prazosin - Pharmacology | en_US |
dc.subject.mesh | Receptors, Adrenergic, Alpha - Physiology | en_US |
dc.subject.mesh | Receptors, Serotonin - Physiology | en_US |
dc.subject.mesh | Serotonin - Pharmacology | en_US |
dc.title | Are there interactions between S2-serotonergic and α1-adrenergic receptors in isolated canine arteries? | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 2459508 | - |
dc.identifier.scopus | eid_2-s2.0-0023677253 | en_US |
dc.identifier.volume | 11 | en_US |
dc.identifier.issue | SUPPL. 1 | en_US |
dc.identifier.spage | S16 | en_US |
dc.identifier.epage | S21 | en_US |
dc.identifier.isi | WOS:A1988P544300005 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Luscher, TF=18935805600 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0160-2446 | - |